Yujin Hoshida
Yujin Hoshida
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
10932008
Lin28 promotes transformation and is associated with advanced human malignancies
SR Viswanathan, JT Powers, W Einhorn, Y Hoshida, TL Ng, S Toffanin, ...
Nature genetics 41 (7), 843, 2009
7252009
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, SR Setlur, ...
Oncogene 26 (31), 4596-4599, 2007
7122007
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ...
Cancer research 69 (18), 7385-7392, 2009
6782009
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
6592008
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
4742008
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
M Yamauchi, T Morikawa, A Kuchiba, Y Imamura, ZR Qian, R Nishihara, ...
Gut 61 (6), 847-854, 2012
4262012
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Z Ding, CJ Wu, GC Chu, Y Xiao, D Ho, J Zhang, SR Perry, ES Labrot, ...
Nature 470 (7333), 269-273, 2011
4182011
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
SR Setlur, KD Mertz, Y Hoshida, F Demichelis, M Lupien, S Perner, ...
Journal of the National Cancer Institute 100 (11), 815-825, 2008
3252008
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ...
Gastroenterology 140 (5), 1501-1512. e2, 2011
3192011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
AJ Bass, MS Lawrence, LE Brace, AH Ramos, Y Drier, K Cibulskis, ...
Nature genetics 43 (10), 964-968, 2011
3172011
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements
Y Hoshida, S Toffanin, A Lachenmayer, A Villanueva, B Minguez, ...
Seminars in liver disease 30 (01), 035-051, 2010
2942010
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
D Sia, Y Hoshida, A Villanueva, S Roayaie, J Ferrer, B Tabak, J Peix, ...
Gastroenterology 144 (4), 829-840, 2013
2852013
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
V Tovar, C Alsinet, A Villanueva, Y Hoshida, DY Chiang, M Solé, S Thung, ...
Journal of hepatology 52 (4), 550-559, 2010
2382010
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice
A Villanueva, C Alsinet, K Yanger, Y Hoshida, Y Zong, S Toffanin, ...
Gastroenterology 143 (6), 1660-1669. e7, 2012
2322012
Hepatic stellate cells as key target in liver fibrosis
T Higashi, SL Friedman, Y Hoshida
Advanced drug delivery reviews 121, 27-42, 2017
2292017
Cancer biomarker discovery and validation
N Goossens, S Nakagawa, X Sun, Y Hoshida
Translational cancer research 4 (3), 256, 2015
2252015
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
P Newell, S Toffanin, A Villanueva, DY Chiang, B Minguez, L Cabellos, ...
Journal of hepatology 51 (4), 725-733, 2009
2232009
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
S Toffanin, Y Hoshida, A Lachenmayer, A Villanueva, L Cabellos, ...
Gastroenterology 140 (5), 1618-1628. e16, 2011
2082011
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
2052014
The system can't perform the operation now. Try again later.
Articles 1–20